CFDE Data Portal | Search LOC124903236

	Label	Description
	LOC124903236 Gene (Entity type)	ENSG00000287996 - uncharacterized LOC124903236
	GSE195568 palbociclib 1 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 clofilium 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204 GSE211619 glutamine 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE188631 DREAM knockout HeLa 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC124903236

ENSG00000287996 - uncharacterized LOC124903236

GSE195568 palbociclib 1 v 10 human up

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn

A Gene Set from LINCS

GSE102467 clofilium 3 v 0 human dn

A Gene Set from LINCS

GSE77108 saha 6 v 9 human up

A Gene Set from LINCS

GSE199204 GSE211619 glutamine 4 v 5 human up

A Gene Set from LINCS

GSE188631 DREAM knockout HeLa 0 v 3 human up

A Gene Set from LINCS

GSE148200 gemcitabine 1 v 2 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.